NHC Reports 2023 Year End Earnings
- None.
- None.
Insights
The reported increase in net operating revenues of 5.1% for National HealthCare Corporation (NHC) is a positive indicator of the company's growth, particularly when considering the exclusion of government stimulus income and the impact of ceasing operations in several facilities. This growth is reflective of an improving operational efficiency and possibly an increase in demand for senior health care services. The significant rise in adjusted net income by 47.2% suggests a robust underlying financial performance, which is critical for investor confidence. The increase in both GAAP and adjusted diluted earnings per share further underscores the company's profitability enhancement over the year.
However, it is important to consider the role that non-GAAP adjustments play in these figures, as they can often provide a more accurate representation of a company's operational performance by excluding one-time events or non-cash expenses. The substantial difference between GAAP and non-GAAP earnings indicates that such adjustments have had a notable impact on NHC's financials and investors should analyze the nature of these adjustments to fully understand the company's financial health.
The senior health care industry is experiencing growth due to demographic trends, such as an aging population, which likely contributes to the increased demand for NHC's services. The 11.3% same-facility net operating revenue growth indicates that NHC is capitalizing on this trend effectively, which is a strong sign for potential investors. Moreover, the company's ability to improve its financials after ceasing operations in select facilities suggests strategic decision-making in optimizing its portfolio of services.
Investors should also consider the broader market implications of NHC's financial performance. A strong earnings report from a leading company in the senior health care sector could signal positive trends for other companies within the industry. It may also attract more investments into the sector as a whole, potentially leading to increased competition and innovation.
From an economic perspective, the reported financial results of NHC may have broader implications on the health care sector and the economy. The company's growth amidst the exclusion of stimulus income suggests resilience to external economic factors, which can be reassuring in times of economic uncertainty. The health care sector is often considered non-cyclical, meaning it is less sensitive to economic downturns, as the demand for health care services remains relatively constant. NHC's performance could therefore be a bellwether for the stability of the health care market.
Furthermore, the increase in earnings and operational efficiency could lead to potential job creation and investments in health care infrastructure. However, it is essential to monitor how changes in health care policies and regulations might impact the sector's long-term growth and profitability.
For the year ended December 31, 2023, the reported GAAP net income attributable to NHC was
For the quarter ended December 31, 2023, the reported GAAP net income attributable to NHC was
(*) - See the tables below that provide a reconciliation of GAAP to non-GAAP items.
About NHC
NHC affiliates operate for themselves and third parties 68 skilled nursing facilities with 8,732 beds. NHC affiliates also operate 26 assisted living communities with 1,501 units, five independent living communities with 475 units, three behavioral health hospitals, 35 homecare agencies, and 30 hospice agencies. NHC’s other services include Alzheimer’s and memory care units, pharmacy services, a rehabilitation services company, and providing management and accounting services to third party post-acute operators. Other information about the company can be found on our web site at www.nhccare.com.
Non-GAAP Financial Presentation
The Company is providing certain non-GAAP financial measures as the Company believes that these figures are helpful in allowing investors to more accurately assess the ongoing nature of the Company’s operations and measure the Company’s performance more consistently across periods. Therefore, the Company believes this information is meaningful in addition to the information contained in the GAAP presentation of financial information. The presentation of this additional non-GAAP financial information is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with GAAP.
Forward-Looking Statements
Statements in this press release that are not historical facts are forward-looking statements. NHC cautions investors that any forward-looking statements made involve risks and uncertainties and are not guarantees of future performance. The risks and uncertainties are detailed from time to time in reports filed by NHC with the S.E.C., including Forms 8-K, 10-Q, and 10-K. All forward-looking statements represent NHC’s best judgment as of the date of this release.
Consolidated Statements of Operations | |||||||||||||||
(in thousands, except share and per share amounts) | |||||||||||||||
Three Months Ended | Years Ended | ||||||||||||||
December 31 | December 31 | ||||||||||||||
|
2023 |
|
|
2022 |
|
|
2023 |
|
|
2022 |
|
||||
Revenues and grant income: | |||||||||||||||
Net patient revenues | $ |
282,997 |
|
$ |
252,424 |
|
$ |
1,087,614 |
|
$ |
1,029,085 |
|
|||
Other revenues |
|
17,917 |
|
|
11,612 |
|
|
53,930 |
|
|
45,196 |
|
|||
Government stimulus income |
|
- |
|
|
517 |
|
|
- |
|
|
11,457 |
|
|||
Net operating revenues and grant income |
|
300,914 |
|
|
264,553 |
|
|
1,141,544 |
|
|
1,085,738 |
|
|||
Costs and expenses: | |||||||||||||||
Salaries, wages and benefits |
|
186,562 |
|
|
167,341 |
|
|
712,344 |
|
|
686,169 |
|
|||
Other operating |
|
70,970 |
|
|
67,365 |
|
|
288,183 |
|
|
285,644 |
|
|||
Facility rent |
|
11,438 |
|
|
10,207 |
|
|
41,525 |
|
|
40,977 |
|
|||
Depreciation and amortization |
|
11,768 |
|
|
10,478 |
|
|
42,034 |
|
|
40,489 |
|
|||
Interest |
|
56 |
|
|
112 |
|
|
324 |
|
|
563 |
|
|||
Total costs and expenses |
|
280,794 |
|
|
255,503 |
|
|
1,084,410 |
|
|
1,053,842 |
|
|||
Income from operations |
|
20,120 |
|
|
9,050 |
|
|
57,134 |
|
|
31,896 |
|
|||
Non-operating income |
|
4,544 |
|
|
2,690 |
|
|
16,660 |
|
|
11,141 |
|
|||
Unrealized gains/(losses) on marketable equity securities |
|
12,001 |
|
|
(4,327 |
) |
|
14,944 |
|
|
(15,806 |
) |
|||
Income before income taxes |
|
36,665 |
|
|
7,413 |
|
|
88,738 |
|
|
27,231 |
|
|||
Income tax provision |
|
(8,700 |
) |
|
(1,839 |
) |
|
(23,450 |
) |
|
(7,254 |
) |
|||
Net income |
|
27,965 |
|
|
5,574 |
|
|
65,288 |
|
|
19,977 |
|
|||
Net loss attributable to noncontrolling interest |
|
441 |
|
|
779 |
|
|
1,510 |
|
|
2,468 |
|
|||
Net income attributable to National HealthCare Corporation | $ |
28,406 |
|
$ |
6,353 |
|
$ |
66,798 |
|
$ |
22,445 |
|
|||
Net income per common share | |||||||||||||||
Basic | $ |
1.86 |
|
$ |
0.41 |
|
$ |
4.36 |
|
$ |
1.46 |
|
|||
Diluted | $ |
1.83 |
|
$ |
0.41 |
|
$ |
4.34 |
|
$ |
1.45 |
|
|||
Weighted average common shares outstanding | |||||||||||||||
Basic |
|
15,306,253 |
|
|
15,326,680 |
|
|
15,310,142 |
|
|
15,410,222 |
|
|||
Diluted |
|
15,486,573 |
|
|
15,358,488 |
|
|
15,377,343 |
|
|
15,447,211 |
|
|||
Dividends declared per common share | $ |
0.59 |
|
$ |
0.57 |
|
$ |
2.34 |
|
$ |
2.26 |
|
|||
Balance Sheet Data | Dec 31, | Dec 31, | |||||||||||||
(in thousands) |
|
2023 |
|
|
2022 |
|
|||||||||
Cash, cash equivalents and marketable securities | $ |
223,620 |
|
$ |
182,589 |
|
|||||||||
Restricted cash, cash equivalents and marketable securities |
|
167,971 |
|
|
158,067 |
|
|||||||||
Current assets |
|
406,235 |
|
|
353,932 |
|
|||||||||
Property and equipment, net |
|
493,329 |
|
|
506,532 |
|
|||||||||
Total assets |
|
1,310,796 |
|
|
1,275,450 |
|
|||||||||
Current liabilities |
|
214,476 |
|
|
197,887 |
|
|||||||||
Stockholders' equity |
|
910,480 |
|
|
877,514 |
|
|||||||||
Selected Operating Statistics | ||||||||||||||||
Three Months Ended | Years Ended | |||||||||||||||
December 31 | December 31 | |||||||||||||||
|
2023 |
|
|
2022 |
|
|
2023 |
|
|
2022 |
|
|||||
Skilled Nursing Per Diems: | ||||||||||||||||
Medicare | $ |
579.84 |
|
$ |
544.11 |
|
$ |
559.07 |
|
$ |
541.23 |
|
||||
Managed Care |
|
478.51 |
|
|
482.99 |
|
|
464.89 |
|
|
439.07 |
|
||||
Medicaid |
|
268.58 |
|
|
236.86 |
|
|
253.95 |
|
|
232.22 |
|
||||
Private Pay and Other |
|
290.85 |
|
|
265.55 |
|
|
282.14 |
|
|
267.50 |
|
||||
Average Skilled Nursing Per Diem | $ |
337.57 |
|
$ |
310.82 |
|
$ |
324.53 |
|
$ |
304.04 |
|
(1) |
|||
Skilled Nursing Patient Days: | ||||||||||||||||
Medicare |
|
79,025 |
|
|
82,965 |
|
|
318,253 |
|
|
341,926 |
|
||||
Managed Care |
|
62,031 |
|
|
51,003 |
|
|
242,023 |
|
|
214,826 |
|
||||
Medicaid |
|
288,538 |
|
|
284,208 |
|
|
1,140,612 |
|
|
1,204,139 |
|
||||
Private Pay and Other |
|
170,916 |
|
|
157,174 |
|
|
663,195 |
|
|
646,651 |
|
||||
Total Skilled Nursing Patient Days |
|
600,510 |
|
|
575,350 |
|
|
2,364,083 |
|
|
2,407,542 |
|
(1) |
|||
(1) For the year ended December 31, 2022, the skilled nursing per diems and patient days listed above include the seven skilled nursing facilities that were located in |
||||||||||||||||
The tables below provide reconciliations of GAAP to non-GAAP items (in thousands, except per share amounts): | ||||||||||||||||
Three Months Ended | Years Ended | |||||||||||||||
December 31 | December 31 | |||||||||||||||
|
2023 |
|
|
2022 |
|
|
2023 |
|
|
2022 |
|
|||||
Net income attributable to National HealthCare Corporation | $ |
28,406 |
|
$ |
6,353 |
|
$ |
66,798 |
|
$ |
22,445 |
|
||||
Non-GAAP adjustments | ||||||||||||||||
Unrealized (gains)/losses on marketable equity securities |
|
(12,001 |
) |
|
4,327 |
|
|
(14,944 |
) |
|
15,806 |
|
||||
Gain on sale of property and equipment |
|
(6,230 |
) |
|
- |
|
|
(6,230 |
) |
|
- |
|
||||
Operating results for newly opened operations not at full capacity (2) |
|
742 |
|
|
1,383 |
|
|
2,359 |
|
|
5,416 |
|
||||
Impairment/(recovery) of assets |
|
- |
|
|
- |
|
|
- |
|
|
(3,728 |
) |
||||
Stock-based compensation expense |
|
663 |
|
|
632 |
|
|
2,782 |
|
|
2,612 |
|
||||
Income tax (benefit)/provision on non-GAAP adjustments |
|
4,375 |
|
|
(1,649 |
) |
|
4,169 |
|
|
(5,228 |
) |
||||
Non-GAAP Net income | $ |
15,955 |
|
$ |
11,046 |
|
$ |
54,934 |
|
$ |
37,323 |
|
||||
GAAP diluted earnings per share | $ |
1.83 |
|
$ |
0.41 |
|
$ |
4.34 |
|
$ |
1.45 |
|
||||
Non-GAAP adjustments | ||||||||||||||||
Unrealized (gains)/losses on marketable equity securities |
|
(0.57 |
) |
|
0.21 |
|
|
(0.72 |
) |
|
0.76 |
|
||||
Gain on sale of property and equipment |
|
(0.30 |
) |
|
(0.30 |
) |
||||||||||
Operating results for newly opened operations not at full capacity (2) |
|
0.04 |
|
|
0.07 |
|
|
0.10 |
|
|
0.26 |
|
||||
Impairment/(recovery) of assets |
|
- |
|
|
- |
|
|
(0.18 |
) |
|||||||
Stock-based compensation expense |
|
0.03 |
|
|
0.03 |
|
|
0.13 |
|
|
0.13 |
|
||||
Non-GAAP diluted earnings per share | $ |
1.03 |
|
$ |
0.72 |
|
$ |
3.55 |
|
$ |
2.42 |
|
||||
(2) The newly opened operations not at full capacity for the 2023 periods presented consisted of operations opened from 2021 through 2023. This consisted of two behavioral health hospitals, two homecare agencies, and two hospice agencies. The newly opened operations for the 2022 periods presented consisted of operations opened from 2020 through 2022. This consisted of two behavioral health hospitals, one homecare agency, and one hospice agency. | ||||||||||||||||
View source version on businesswire.com: https://www.businesswire.com/news/home/20240216747110/en/
Brian F. Kidd, SVP/CFO
Phone: (615) 890-2020
Source: National HealthCare Corporation
FAQ
What were NHC's net operating revenues for the year ended December 31, 2023?
What was the percentage increase in NHC's net operating revenues for 2023 compared to 2022?
How did NHC's adjusted net income change from 2022 to 2023?
What were NHC's GAAP diluted earnings per share for the year ended December 31, 2023?